Imunon, Inc. — Director's Dealing 2026

Jan 20, 2026

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Imunon, Inc. (IMNN)
CIK: 0000749647
Period of Report: 2026-01-15

Reporting Person: CHURCH JEFFREY WAYNE (CFO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	26	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$9.2000	2035-08-04	Common Stock (167)		Direct
Stock Option (Right to Buy)	$3.9500	2036-01-02	Common Stock (5000)		Direct

Footnotes

F1: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.